MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Genetics"

  • MDS Virtual Congress 2021

    DNA methylation of CDKN2B/CDKN2B-AS1 enhancer in Huntington’s disease and lung cancer

    I. Goncharova, E. Bragina, D. Gomboeva, N. Babushkina, A. Markov, M. Nazarenko, M. Nikitina, V. Alifirova, N. Zhukova, S. Illarioshkin, V. Puzyrev (Tomsk, Russian Federation)

    Objective: The aim of this study was to evaluate the DNA methylation of the CDKN2B/CDKN2B-AS1 enhancer with Huntington's disease and lung cancer. Background: Phenomenon of…
  • MDS Virtual Congress 2021

    Genetic features and long-term outcome of Korean patients with Huntington’s disease.

    YS. Hwang, SY. Jo, SH. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: To investigate the genetic characteristics and long-term outcome of Korean patients with Huntington’s disease. Background: Huntington’s disease is an autosomal dominant neurodegenerative disease, which…
  • MDS Virtual Congress 2021

    Cost of Predictive Genetic Testing for Huntington’s Disease at Centers of Excellence in the US

    M. Massey, T. Orem, V. Sung (Birmingham, USA)

    Objective: To characterize the cost of Huntington’s disease predictive genetic testing at Centers of Excellence in the US. Background: Despite the availability of predictive genetic…
  • MDS Virtual Congress 2021

    Risk and timing of manifest Huntington’s disease in patients with reduced penetrance alleles

    E. Mcdonnell, Y. Wang, K. Marder (New York, USA)

    Objective: To estimate risk of Huntington’s disease (HD) over time in patients with reduced penetrance (RP) alleles (36-39 CAG repeats) overall, by individual repeat length,…
  • MDS Virtual Congress 2021

    Quantifying Tremor in the R6/2 Mouse model of Huntington’s Diease

    H. Skelton, D. Grogan, J. Rubiano, R. Gross, C. Gutekunst (Atlanta, USA)

    Objective: To better characterize and precisely quantify the tremor widely observed in R6/2 mouse models of Huntington’s disease. Background: Tremor is a prominent feature of…
  • MDS Virtual Congress 2021

    Mobile application for assessing the likelihood of developing depression in patients with Parkinson’s disease

    M. Nikitina, A. Bragin, E. Bragina, V. Alifirova, N. Zhukova, D. Gomboeva, V. Spitsyn (Tomsk, Russian Federation)

    Objective: To develop a mobile application for assessing the likelihood of developing depression in patients with Parkinson's disease (PwPD), taking into account the number of…
  • MDS Virtual Congress 2021

    GNAO1 related movement disorders: 2 longitudinally-followed cases

    CC. Wang, S. Lee (Lebanon, USA)

    Objective: To describe the clinical course, phenomenology, and treatment response in two patients with GNAO1 related movement disorders. Background: Since the initial report of 4…
  • MDS Virtual Congress 2020

    The genetic study of hereditary chorea in Kazakhstan

    R. Kaiyrzhanov, N. Zharkinbekova, A. Aitkulova, V. Akhmetzhanov, Z. Jarmukhanov, H. Houlden (London, United Kingdom)

    Objective: To analyze the genetic background of hereditary chorea in Kazakhstani population. Background: Hereditary chorea (HC) is a group of inherited movement disorders presenting with…
  • MDS Virtual Congress 2020

    Longitudinal dynamics of mutant huntingtin and neurofilament light in Huntington’s disease: the prospective HD-CSF study

    F. Rodrigues, L. Byrne, R. Tortelli, E. Johnson, P. Wijeratne, M. Arridge, E. De Vita, D. Alexander, S. Tabrizi, S. Schobel, R. Scahill, A. Heslegrave, H. Zetterberg, E. Wild (London, United Kingdom)

    Objective: To present the mutant huntingtin (mHTT) and neurofilament light (NfL) findings from the two-year prospective longitudinal HD-CSF study, in which an 80-participant cohort of…
  • MDS Virtual Congress 2020

    SCA48: Ataxia Plus Chorea in a New Spanish Family

    M.I Gastón, G. Soriano, A. Alonso, S. Pasalodos, J. Salgado, M. Mendioroz (Pamplona, Spain)

    Objective: To describe a new family with Spinocerebellar Ataxia 48 (SCA48) characterized by ataxia and mild chorea as the most prominent initial symptoms as well…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley